Concepedia

V. Deshmukh

VD

Statistics

Publications

10

Citations

1.5K

H-Index

10

Active since

2013

Affiliations

Scripps Research Institute(Current)

California Institute for Biomedical Research

Samumed (United States)

Torrey Pines Institute For Molecular Studies

Ambrx (United States)

V. Deshmukh is an author at Scripps Research Institute specializing in pharmacology, medicine, and cell signaling.

Publications per year

2013–2020

10

Publications

10

A regenerative approach to the treatment of multiple sclerosis

V. Deshmukh, Virginie Tardif, Costas A. Lyssiotis et al. · Nature · 2013 · 515 citations · Full text

Life Sciences, Neurology, Neuroscience +14

A small-molecule inhibitor of the Wnt pathway (SM04690) as a potential disease modifying agent for the treatment of osteoarthritis of the knee

V. Deshmukh, Haide Hu, Charlene F. Barroga et al. · Osteoarthritis and Cartilage · 2017 · 223 citations · Full text

Medicine, Orthopaedic Surgery, Orthopedic Surgery +17

Modulation of the Wnt pathway through inhibition of CLK2 and DYRK1A by lorecivivint as a novel, potentially disease-modifying approach for knee osteoarthritis treatment

V. Deshmukh, Alyssa L. O'Green, Carine Bossard et al. · Osteoarthritis and Cartilage · 2019 · 193 citations · Full text

Medicine, Orthopaedic Surgery, Pharmacology +17

The CLK inhibitor SM08502 induces anti-tumor activity and reduces Wnt pathway gene expression in gastrointestinal cancer models

Betty Y. Tam, Kevin Chiu, Heekyung Chung et al. · Cancer Letters · 2019 · 143 citations · Full text

Medicine, Oncology, Pharmacology +17

An Immunosuppressive Antibody–Drug Conjugate

Rongsheng E. Wang, Tao Liu, Ying Wang et al. · Journal of the American Chemical Society · 2015 · 107 citations

Pharmacy, Oncology, Pharmacology +17

1–5 of 10